Innovent Biologics, Inc. (IVBXF)
OTCMKTS · Delayed Price · Currency is USD
12.03
-1.62 (-11.87%)
Sep 8, 2025, 2:50 PM EDT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of $22.09 billion as of September 8, 2025. Its market cap has increased by 152.88% in one year.
Market Cap
22.09B
Enterprise Value
21.22B
Revenue
1.59B
Ranking
n/a
PE Ratio
139.75
Stock Price
$12.03
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 2.36B to 22.09B, an increase of 834.39%. That is a compound annual growth rate of 38.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2025 | 22.09B | 186.17% |
| Dec 31, 2024 | 7.72B | -12.83% |
| Dec 29, 2023 | 8.85B | 34.32% |
| Dec 30, 2022 | 6.59B | -27.14% |
| Dec 31, 2021 | 9.05B | -39.06% |
| Dec 31, 2020 | 14.84B | 244.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 825.37M |
| Elite Pharmaceuticals | 749.52M |
| Tian'an Technology Group | 705.53M |
| Glass House Brands | 600.00M |
| HealthLynked | 499.79M |
| CytoDyn | 396.74M |
| Northwest Biotherapeutics | 376.41M |